Preprints with The Lancet is part of SSRN´s First Look, a place where journals identify content of interest prior to publication. Authors have opted in at submission to The Lancet family of journals to post their preprints on Preprints with The Lancet. The usual SSRN checks and a Lancet-specific check for appropriateness and transparency have been applied. Preprints available here are not Lancet publications or necessarily under review with a Lancet journal. These preprints are early stage research papers that have not been peer-reviewed. The findings should not be used for clinical or public health decision making and should not be presented to a lay audience without highlighting that they are preliminary and have not been peer-reviewed. For more information on this collaboration, see the comments published in The Lancet about the trial period, and our decision to make this a permanent offering, or visit The Lancet´s FAQ page, and for any feedback please contact firstname.lastname@example.org.
Prevalence, Awareness, Treatment, and Control of Diabetes in India: A Nationally Representative Survey of Adults Aged 45 Years and Older
39 Pages Posted: 24 Mar 2022More...
Background: India is a country of 1.4 billion people that contributes to much of the global diabetes burden. Updated evidence on the state of the diabetes epidemic among middle-aged and older adults is imperative given that the risk of diabetes rises with age and that clinical and public health interventions can prevent diabetes complications. We estimated the prevalence, awareness, treatment, and control of diabetes in a nationally representative and state-representative sample of Indians aged 45 years and older.
Methods: We conducted a cross-sectional survey of adults aged 45 years and older from 2017 to 2019. Our sample included 56,995 individuals from 35 states and union territories, reflecting a representative sample of India as a nation and of each state and union territory. Our primary outcomes were diabetes prevalence and health service indicators recommended by the World Health Organization. Diabetes prevalence was defined as individuals self-reporting a prior diabetes diagnosis or having hemoglobin A1c (HbA1c) ≥6.5%. Diabetes health service indicators were based on four core metrics recommended by the World Health Organization: (1) proportion diagnosed out of all individuals with diabetes ('awareness') and out of individuals with diagnosed diabetes, (2) proportion with glycemic control (HbA1c <7%), (3) proportion with blood pressure control (<140/90 mmHg), and (4) proportion using lipid-lowering medications. Outcomes were assessed in the national sample; by state and union territory; and across individual-level characteristics of age, sex, rural versus urban area of residence, education, economic status, and body mass index.
Findings: Diabetes prevalence among adults aged 45 years and older in India was 19.7% (95% confidence interval 19.3% to 20.1%), which amounts to 50.1 (49.1 to 51.1) million people. Prevalence among men and women was similar (19.5% [18.9% to 20.1%] and 20.0% [19.4% to 20.6%], respectively). Urban diabetes prevalence (29.9% [29.0% to 30.7%]) was approximately twice as high as rural prevalence (14.9% [14.5% to 15.4%]). States with higher levels of economic development and in southern India tended to have greater age-standardized prevalence. Overall, 60.4% (59.3% to 61.5%) of individuals were aware of their diabetes. Out of individuals with diagnosed diabetes, 46.1% (44.7% to 47.6%) achieved glycemic control, 58.9% (57.4% to 60.3%) achieved blood pressure control, and 6.5% (5.8% to 7.2%) were taking a lipid-lowering medication.
Interpretation: Our findings emphasize the urgent need to scale up policies to better prevent, detect, manage, and control diabetes among middle-aged and older adults in India.
Funding Information: National Institute on Aging, National Institutes of Health and the Ministry of Health and Family Welfare, Government of India.
Declaration of Interests: We declare no competing interests.
Ethics Approval Statement: LASI obtained approval from the University of Southern California Institutional Review Board (IRB) (UP-CG-14_00005), the Harvard University IRB (CR-16715-10), the International Institute for Population Sciences IRB (Sr. No. 12/1054), and Health Ministry’s Screening Committee clearance from the Indian Council of Medical Research (F.No.T.21012/07/ 2012-NCD). Each LASI participant provided written consent for participation.
Keywords: diabetes mellitus, public health, epidemiology, health policy, Primary Health Care
Suggested Citation: Suggested Citation